AtriCure Inc
ATRC
ISIN null / Valor 2134051
AtriCure Inc
UMushroom community rating:
About company
AtriCure Inc. is a prominent medical device company specializing in the development and provision of advanced technologies aimed at the treatment of Atrial Fibrillation (Afib) and related cardiac conditions. The company has established itself as a trusted partner for electrophysiologists and cardiothoracic surgeons globally, offering a range of products designed to address complex cardiac cases. Among its notable innovations is the Isolator® Synergy™ Ablation System, distinguished as the first device of its kind to receive FDA approval for the treatment of persistent Afib. Additionally, AtriCure's AtriClip Left Atrial Appendage Exclusion System stands out as the most extensively utilized device worldwide for left atrial appendage management. The company also offers the Hybrid AF™ Therapy, a minimally invasive approach catering to patients with long-standing persistent Afib, and the cryoICE cryoSPHERE® probe, which is approved for the temporary ablation of peripheral nerves to alleviate pain during cardiac and thoracic surgeries. AtriCure is committed to advancing the field of cardiac care through continuous investment in innovation, clinical science, and educational initiatives aimed at enhancing patient outcomes globally.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (13.10.2025):
AtriCure Inc reported its financial results for the first quarter of 2025, demonstrating growth in revenue and improvements in net loss and adjusted EBITDA compared to the same period last year.
Revenue Growth
AtriCure Inc achieved worldwide revenue of $123.6 million in Q1 2025, marking a 13.6% increase year-over-year (14.1% on a constant currency basis).
Improved Net Loss
The company reported a net loss of $6.7 million in Q1 2025, an improvement of $6.5 million compared to Q1 2024.
Adjusted EBITDA Increase
Adjusted EBITDA for Q1 2025 reached $8.8 million, up $6.0 million year-over-year.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1798 M
Market cap (USD)
571,216
Daily traded volume (Shares)
30.67 / 29.85
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
